HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.

AbstractCONTEXT:
Melanocortin receptor 4 (MC4R) deficiency is characterized by increased linear growth greater than expected for the degree of obesity.
OBJECTIVE:
The objective of the investigation was to study the somatotroph axis in obese MC4R-deficient patients and equally obese controls.
PATIENTS AND METHODS:
We obtained anthropometric measurements and insulin concentrations in 153 MC4R-deficient subjects and 1392 controls matched for age and severity of obesity. We measured fasting IGF-I, IGF-II, IGF binding protein (IGFBP)-1, IGFBP-3, and acid-labile subunit levels in a subset of 33 MC4R-deficient patients and 36 control subjects. We examined pulsatile GH secretion in six adult MC4R-deficient subjects and six obese controls.
RESULTS:
Height sd score was significantly greater in MC4R-deficient children under 5 yr of age compared with controls (mean ± SEM: 2.3 ± 0.06 vs. 1.8 ± 0.04, P < 0.001), an effect that persisted throughout childhood. Final height (cm) was greater in MC4R-deficient men (mean ± SEM 173 ± 2.5 vs. 168 ± 2.1, P < 0.001) and women (mean 165 ± 2.1 vs. 158 ± 1.9, P < 0.001). Fasting IGF-I, IGF-II, acid-labile subunit, and IGFBP-3 concentrations were similar in the two groups. GH levels were markedly suppressed in obese controls, but pulsatile GH secretion was retained in MC4R deficiency. The mean maximal GH secretion rate per burst (P < 0.05) and mass per burst (P < 0.05) were increased in MC4R deficiency, consistent with increased pulsatile and total GH secretion. Fasting insulin levels were markedly elevated in MC4R-deficient children.
CONCLUSIONS:
In MC4R deficiency, increased linear growth in childhood leads to increased adult final height, greater than predicted by obesity alone. GH pulsatility is maintained in MC4R deficiency, a finding consistent with animal studies, suggesting a role for MC4R in controlling hypothalamic somatostatinergic tone. Fasting insulin levels are significantly higher in children carrying MC4R mutations. Both of these factors may contribute to the accelerated growth phenotype characteristic of MC4R deficiency.
AuthorsCarlos E Martinelli, Julia M Keogh, Jerry R Greenfield, Elana Henning, Agatha A van der Klaauw, Anthea Blackwood, Stephen O'Rahilly, Ferdinand Roelfsema, Cecilia Camacho-Hübner, Hanno Pijl, I Sadaf Farooqi
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 96 Issue 1 Pg. E181-8 (Jan 2011) ISSN: 1945-7197 [Electronic] United States
PMID21047921 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Glycoproteins
  • Insulin
  • Insulin-Like Growth Factor Binding Protein 1
  • Insulin-Like Growth Factor Binding Protein 3
  • Receptor, Melanocortin, Type 4
  • insulin-like growth factor binding protein, acid labile subunit
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
Topics
  • Anthropometry
  • Body Height (genetics)
  • Carrier Proteins (blood)
  • Female
  • Glycoproteins (blood)
  • Human Growth Hormone (deficiency, metabolism)
  • Humans
  • Hyperinsulinism (complications, genetics, metabolism)
  • Immunoassay
  • Insulin (blood)
  • Insulin-Like Growth Factor Binding Protein 1 (blood)
  • Insulin-Like Growth Factor Binding Protein 3 (blood)
  • Insulin-Like Growth Factor I (metabolism)
  • Insulin-Like Growth Factor II (metabolism)
  • Male
  • Mutation
  • Obesity (complications, genetics, metabolism)
  • Receptor, Melanocortin, Type 4 (deficiency, genetics)
  • Severity of Illness Index
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: